Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2777 studies found for:    "Prostatic Neoplasms"
Show Display Options
Rank Status Study
21 Terminated
Has Results
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Castrate-resistant Prostate Cancer (CRPC);   Androgen-insensitive Prostate Cancer;   Hormone-refractory Prostate Cancer;   Metastatic Disease
Intervention: Drug: Itraconazole
22 Enrolling by invitation Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer;   Cancer of the Prostate
Interventions: Device: High-resolution ultrasound guided prostate biopsy;   Device: Standard ultrasound guided prostate biopsy
23 Terminated
Has Results
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Castrate-resistant Prostate Cancer (CRPC);   Androgen-insensitive Prostate Cancer;   Hormone-refractory Prostate Cancer;   Metastatic Disease
Interventions: Drug: Temsirolimus;   Drug: Casodex (bicalutamide)
24 Recruiting Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention:
25 Recruiting Study of Metformin With Simvastatin for Men With Prostate Carcinoma
Condition: Prostate Carcinoma
Interventions: Drug: Metformin;   Drug: Simvastatin
26 Terminated
Has Results
Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Imatinib Mesylate
27 Active, not recruiting NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Drug: TAK-700
28 Active, not recruiting A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Conditions: Prostate Neoplasms;   Prostate Cancer
Interventions: Drug: Cohort 4;   Drug: Cohort 3;   Drug: Cohort 2;   Drug: Cohort 1
29 Active, not recruiting Sipuleucel-T Manufacturing Demonstration Study
Conditions: Cancer of Prostate;   Cancer of the Prostate;   Neoplasms, Prostate;   Neoplasms, Prostatic;   Prostate Cancer;   Prostate Neoplasms;   Prostatic Cancer
Intervention: Biological: sipuleucel-T
30 Completed Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer
Conditions: Hematologic Neoplasms;   Prostatic Neoplasms
Intervention: Drug: APR-246
31 Completed Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Leuprolide acetate
32 Completed Vector Delivery of the IL-12 Gene in Men With Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Genetic: IL-12 gene
33 Completed PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
Conditions: Prostate Cancer;   Prostate Neoplasm
Interventions: Drug: rV-PSA;   Drug: rF-PSA;   Drug: rV-B7.1
34 Recruiting A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Intervention: Drug: JNJ-56021927
35 Withdrawn Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage II Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Prednisone
36 Unknown  Far Infrared Radiation Treatment for Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Radiation: Far Infrared Radiation
37 Active, not recruiting An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Condition: Advanced Prostate Carcinoma
Intervention: Drug: Eligard 45 mg Exposure
38 Not yet recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Intervention: Drug: onapristone
39 Completed
Has Results
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Neoplasms;   Prostate Cancer
Interventions: Drug: Abiraterone;   Drug: Prednisone
40 Completed Phase II Study of ASP3550 in Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: ASP3550

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years